Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab

Erdem Kolemen, Kazım Uygun, Devrim Çabuk, Mustafa Erman, Saadettin Kılıçkap, Tolga Köseci, Duygu Bayır, Oktay Bozkurt, Deniz Can Güven, Hacer Demir, Muslih Urun, Sedat Yıldız, Teoman Sakalar, Nargiz Majidova, Emel Mutlu Özkan, Cengiz Akosman, Muhammet Cengiz, Mustafa Ersoy, Elif Şahin, Pervin Can Sancı, Ayşe Nuransoy Cengiz, Gözde Ağdaş, Erkam Kocaaslan, Ezgi Türkoğlu, Sedat Yıldırım, Berrak Mermit Erçek, Anıl Karakayalı, Hayati Arvas, Mehmet Mutlu Kıdı, Sedat Biter, Havva Yeşil Cinkir, Latif Karahan, Aslıhan Ezgi Apaydın Rollas, Umut Kefeli

Open source

DOI: 10.1007/s12672-026-04859-8
Published: 2026-04-21
Container: Discover Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12672-026-04859-8,
  title = {Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab},
  author = {Erdem Kolemen and Kazım Uygun and Devrim Çabuk and Mustafa Erman and Saadettin Kılıçkap and Tolga Köseci and Duygu Bayır and Oktay Bozkurt and Deniz Can Güven and Hacer Demir and Muslih Urun and Sedat Yıldız and Teoman Sakalar and Nargiz Majidova and Emel Mutlu Özkan and Cengiz Akosman and Muhammet Cengiz and Mustafa Ersoy and Elif Şahin and Pervin Can Sancı and Ayşe Nuransoy Cengiz and Gözde Ağdaş and Erkam Kocaaslan and Ezgi Türkoğlu and Sedat Yıldırım and Berrak Mermit Erçek and Anıl Karakayalı and Hayati Arvas and Mehmet Mutlu Kıdı and Sedat Biter and Havva Yeşil Cinkir and Latif Karahan and Aslıhan Ezgi Apaydın Rollas and Umut Kefeli},
  year = {2026},
  journal = {Discover Oncology},
  doi = {10.1007/s12672-026-04859-8},
  url = {https://doi.org/10.1007/s12672-026-04859-8}
}

RIS

TY  - JOUR
TI  - Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab
AU  - Erdem Kolemen
AU  - Kazım Uygun
AU  - Devrim Çabuk
AU  - Mustafa Erman
AU  - Saadettin Kılıçkap
AU  - Tolga Köseci
AU  - Duygu Bayır
AU  - Oktay Bozkurt
AU  - Deniz Can Güven
AU  - Hacer Demir
AU  - Muslih Urun
AU  - Sedat Yıldız
AU  - Teoman Sakalar
AU  - Nargiz Majidova
AU  - Emel Mutlu Özkan
AU  - Cengiz Akosman
AU  - Muhammet Cengiz
AU  - Mustafa Ersoy
AU  - Elif Şahin
AU  - Pervin Can Sancı
AU  - Ayşe Nuransoy Cengiz
AU  - Gözde Ağdaş
AU  - Erkam Kocaaslan
AU  - Ezgi Türkoğlu
AU  - Sedat Yıldırım
AU  - Berrak Mermit Erçek
AU  - Anıl Karakayalı
AU  - Hayati Arvas
AU  - Mehmet Mutlu Kıdı
AU  - Sedat Biter
AU  - Havva Yeşil Cinkir
AU  - Latif Karahan
AU  - Aslıhan Ezgi Apaydın Rollas
AU  - Umut Kefeli
PY  - 2026
JO  - Discover Oncology
DO  - 10.1007/s12672-026-04859-8
UR  - https://doi.org/10.1007/s12672-026-04859-8
ER  -

APA

Kolemen, E., Uygun, K., Çabuk, D., Erman, M., Kılıçkap, S., Köseci, T., Bayır, D., Bozkurt, O., Güven, D. C., Demir, H., Urun, M., Yıldız, S., Sakalar, T., Majidova, N., Özkan, E. M., Akosman, C., Cengiz, M., Ersoy, M., Şahin, E., Sancı, P. C., Cengiz, A. N., Ağdaş, G., Kocaaslan, E., Türkoğlu, E., Yıldırım, S., Erçek, B. M., Karakayalı, A., Arvas, H., Kıdı, M. M., Biter, S., Cinkir, H. Y., Karahan, L., Rollas, A. E. A., & Kefeli, U. (2026). Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab. Discover Oncology. https://doi.org/10.1007/s12672-026-04859-8

Source records

crossref · retrieved 2026-09-26T19:41:51.165Z